Who
David M. Epstein
Director
Company insider
Files Form 4 as: Director, Gyre Therapeutics; Director and Officer, Black Diamond Therapeutics; Director, MetaStat; Sr. VP and CSO, Oncology, Osi Pharmaceuticals.
In numbers
- Trades disclosed
- 48
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $1.7M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 1 May 2010
- Last trade
- 10 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 30 Jun 2026 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 10 Jun 2026filed 30 Jun 2026 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 14 Aug 2024filed 16 Aug 2024 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,000 at $0.00 | filing |
| 6 Aug 2024filed 8 Aug 2024 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,866 at $0.00 | filing |
| 27 Jun 2023filed 28 Jun 2023 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $168K25,000 at $6.70 | filing |
| 13 Feb 2023filed 15 Feb 2023 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —420,000 at $0.00 | filing |
| 15 Feb 2022filed 17 Feb 2022 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 17 Feb 2021filed 19 Feb 2021 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 4 Jan 2021filed 6 Jan 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code M | $19K3,000 at $6.42 | filing |
| 4 Jan 2021filed 6 Jan 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $309K9,985 at $30.99 | filing |
| 4 Jan 2021filed 6 Jan 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $64K2,015 at $31.80 | filing |
| 4 Jan 2021filed 6 Jan 2021 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
| 15 Dec 2020filed 16 Dec 2020 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 15 Dec 2020filed 16 Dec 2020 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code M | $16K2,500 at $6.42 | filing |
| 1 Dec 2020filed 3 Dec 2020 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
| 1 Dec 2020filed 3 Dec 2020 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code M | $19K3,000 at $6.42 | filing |
| 1 Dec 2020filed 3 Dec 2020 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $357K10,923 at $32.64 | filing |
| 1 Dec 2020filed 3 Dec 2020 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $36K1,077 at $33.45 | filing |
| 2 Nov 2020filed 3 Nov 2020 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
News
Reviewing Black Diamond Therapeutics (NASDAQ:BDTX) & Sera Prognostics (NASDAQ:SERA)BDTX · tickerreport.com · 22 Oct 2026Comparing Black Diamond Therapeutics (NASDAQ:BDTX) & Entrada Therapeutics (NASDAQ:TRDA)BDTX · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name David M. Epstein; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.